LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 81ST LEGISLATIVE REGULAR SESSION April 20, 2009 TO: Honorable Judith Zaffirini, Chair, Senate Committee on Higher Education FROM: John S. O'Brien, Director, Legislative Budget Board IN RE:SB1524 by Shapleigh (Relating to a report regarding research funds received by public institutions of higher education or employees of those institutions from pharmaceutical companies.), As Introduced No significant fiscal implication to the State is anticipated. Under the provisions of the bill, institutions of higher education would be required to report biennially to the Texas Higher Education Coordinating Board the amount of money received by the institution or by individual faculty or staff members of the institution from phramacuetical companies in the two preceeding state fiscal years in connection with research or related activities developed or conducted at the institution or at a research facility operated or administered by the institution. It is assumed institutions of higher education and the Texas Higher Education Coordinating Board would be able to absorb any costs associated with implementing the provisions of the bill within existing resources. Local Government Impact No fiscal implication to units of local government is anticipated. Source Agencies:710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration, 758 Texas State University System, 768 Texas Tech University System Administration, 769 University of North Texas System Administration, 781 Higher Education Coordinating Board LBB Staff: JOB, KK, RT, GO, SK
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 81ST LEGISLATIVE REGULAR SESSION
April 20, 2009
TO: Honorable Judith Zaffirini, Chair, Senate Committee on Higher Education FROM: John S. O'Brien, Director, Legislative Budget Board IN RE:SB1524 by Shapleigh (Relating to a report regarding research funds received by public institutions of higher education or employees of those institutions from pharmaceutical companies.), As Introduced
TO: Honorable Judith Zaffirini, Chair, Senate Committee on Higher Education
FROM: John S. O'Brien, Director, Legislative Budget Board
IN RE: SB1524 by Shapleigh (Relating to a report regarding research funds received by public institutions of higher education or employees of those institutions from pharmaceutical companies.), As Introduced
Honorable Judith Zaffirini, Chair, Senate Committee on Higher Education
Honorable Judith Zaffirini, Chair, Senate Committee on Higher Education
John S. O'Brien, Director, Legislative Budget Board
John S. O'Brien, Director, Legislative Budget Board
SB1524 by Shapleigh (Relating to a report regarding research funds received by public institutions of higher education or employees of those institutions from pharmaceutical companies.), As Introduced
SB1524 by Shapleigh (Relating to a report regarding research funds received by public institutions of higher education or employees of those institutions from pharmaceutical companies.), As Introduced
No significant fiscal implication to the State is anticipated.
No significant fiscal implication to the State is anticipated.
Under the provisions of the bill, institutions of higher education would be required to report biennially to the Texas Higher Education Coordinating Board the amount of money received by the institution or by individual faculty or staff members of the institution from phramacuetical companies in the two preceeding state fiscal years in connection with research or related activities developed or conducted at the institution or at a research facility operated or administered by the institution. It is assumed institutions of higher education and the Texas Higher Education Coordinating Board would be able to absorb any costs associated with implementing the provisions of the bill within existing resources.
Under the provisions of the bill, institutions of higher education would be required to report biennially to the Texas Higher Education Coordinating Board the amount of money received by the institution or by individual faculty or staff members of the institution from phramacuetical companies in the two preceeding state fiscal years in connection with research or related activities developed or conducted at the institution or at a research facility operated or administered by the institution.
It is assumed institutions of higher education and the Texas Higher Education Coordinating Board would be able to absorb any costs associated with implementing the provisions of the bill within existing resources.
Local Government Impact
No fiscal implication to units of local government is anticipated.
Source Agencies: 710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration, 758 Texas State University System, 768 Texas Tech University System Administration, 769 University of North Texas System Administration, 781 Higher Education Coordinating Board
710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration, 758 Texas State University System, 768 Texas Tech University System Administration, 769 University of North Texas System Administration, 781 Higher Education Coordinating Board
LBB Staff: JOB, KK, RT, GO, SK
JOB, KK, RT, GO, SK